A combination of two drugs – dutasteride and solifenacin – might result in improved sexual satisfaction among men with benign prostatic hyperplasia (BPH) accompanied by lower urinary tract symptoms (LUTS). BPH is the medical term for an enlarged prostate, which affects an estimated 50% to 75% of men over age 50. The prostate gland grows […]
Archives for 2018
Impact of Pelvic Radiation Therapy on Inflatable Penile Prosthesis Reoperation Rates Ron Golan MD; Neal A. Patel MD; Tianyi Sun MS; Christopher E. Barbieri MD, PhD; Art Sedrakyan MD, PhD; James A. Kashanian MD FIRST PUBLISHED: November 2018 – The Journal of Sexual Medicine DOI: https://doi.org/10.1016/j.jsxm.2018.09.009 Introduction Radical prostatectomy (RP) and radiation therapy (RT) […]
Older men and women can age successfully, even if their sexual interest and enjoyment wanes as they get older, according to a recent study of European populations. “Sustained sexual interest and sexual enjoyment are linked to successful aging in both genders,” the authors concluded. Published online in September in the Journal of Sexual Medicine, the […]
Dear Members and colleagues of the ISSM, Where did 2018 go! We are approaching the end of the year, one year full of activities for ISSM and in the field of sexual medicine in general. First of all, the World Meeting on Sexual Medicine in Lisbon, Portugal in February 2018, organized together with the ESSM […]
Researchers have discovered a combination of compounds that may help in the treatment of Peyronie’s disease in its active phase, according to a recent study in European Urology. After testing 21 substances in an phenotypic screening assay and working with rat models, they determined that the combination of vardenafil [a phosphodiesterase type 5 (PDE5) inhibitor] […]
Dr. Trinity J. Bivalacqua of the Johns Hopkins School of Medicine has won of the American Urological Association’s 2019 Gold Cystoscope Award. The award was given in acknowledgement of Dr. Bivalacqua’s “innovative translational research and significant contributions to the fields of sexual dysfunction and urologic oncology,” according to the AUA website. Congratulations, Dr. Bivalacqua!